Article Details

Sangamo reclaims rights to hemophilia gene therapy By Investing.com

Retrieved on: 2024-12-30 21:28:47

Tags for this article:

Click the tags to see associated articles and topics

Sangamo reclaims rights to hemophilia gene therapy By Investing.com. View article details on hiswai:

Excerpt

The company also highlighted its partnerships with Genentech and Astellas, along with advanced discussions for its Fabry gene therapy program, as ...

Article found on: www.investing.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up